Vishnu Revuri

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 6

Top Topics

Toll Like Receptor

Reactive Oxygen Species

Dendritic Cells

Top Venues

ACS applied materials & interfaces

This page only lists publications with an associated author ORCID identifier.

Publications

Adityanarayan Mohapatra, Santhosh Kalash Rajendrakumar, Gopalakrishnan Chandrasekaran, Vishnu Revuri, Padmanaban Sathiyamoorthy, Yong-Kyu Lee, Jae Hyuk Lee, Seok-Yong Choi, In-Kyu Park
Biomineralized Nanoscavenger Abrogates Proinflammatory Macrophage Polarization and Induces Neutrophil Clearance through Reverse Migration during Gouty Arthritis. ACS applied materials & interfaces 15 (3) (2023)
Adityanarayan Mohapatra, Santhosh Kalash Rajendrakumar, Gopalakrishnan Chandrasekaran, Vishnu Revuri, Padmanaban Sathiyamoorthy, Yong-Kyu Lee, Jae Hyuk Lee, Seok-Yong Choi, In-Kyu Park
Biomineralized Nanoscavenger Abrogates Proinflammatory Macrophage Polarization and Induces Neutrophil Clearance through Reverse Migration during Gouty Arthritis. ACS applied materials & interfaces 15 (3) (2023)
Adityanarayan Mohapatra, Jagannath Mondal, Padmanaban Sathiyamoorthy, Ayeskanta Mohanty, Vishnu Revuri, Santhosh Kalash Rajendrakumar, Yong-Kyu Lee, In-Kyu Park
Thermosusceptible Nitric-Oxide-Releasing Nitrogel for Strengthening Antitumor Immune Responses with Tumor Collagen Diminution and Deep Tissue Delivery during NIR Laser-Assisted Photoimmunotherapy. ACS applied materials & interfaces (2023)
Adityanarayan Mohapatra, Santhosh Kalash Rajendrakumar, Gopalakrishnan Chandrasekaran, Vishnu Revuri, Padmanaban Sathiyamoorthy, Yong-Kyu Lee, Jae Hyuk Lee, Seok-Yong Choi, In-Kyu Park
Biomineralized Nanoscavenger Abrogates Proinflammatory Macrophage Polarization and Induces Neutrophil Clearance through Reverse Migration during Gouty Arthritis. ACS applied materials & interfaces (2023)
Shubhmita Bhatnagar, Vishnu Revuri, Manan Shah, Peter Larson, Zekun Shao, Daohai Yu, Swayam Prabha, Thomas S Griffith, David M Ferguson, Jayanth Panyam
Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy. Cancers 14 (24) (2022)
Shubhmita Bhatnagar, Vishnu Revuri, Manan Shah, Peter Larson, Zekun Shao, Daohai Yu, Swayam Prabha, Thomas S Griffith, David M Ferguson, Jayanth Panyam
Combination of STING and TLR 7/8 Agonists as Vaccine Adjuvants for Cancer Immunotherapy. Cancers 14 (24) (2022)